Using a xenograft mouse model of colon cancer, Yue and coauthors demonstrated that the peritumoral administration of TSLP reduces tumor growth by inducing the apoptosis of human colon cancer cells in a TSLPR-dependent manner [91]. Here, TSLP is linked to malignant colon neoplasm.